Small Extracellular Vesicles Engineered Using Click Chemistry to Express Chimeric Antigen Receptors Show Enhanced Efficacy in Acute Liver Failure
Journal of Extracellular Vesicles · 2025-02 · 14 (2)
DOI: 10.1002/jev2.70044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 03.02.2025. Verfasst von Yen-Ting Lu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Pharmacology, National Taiwan University College of Medicine, Taipei, Taiwan. Hauptthemen laut MEDLINE: Liver Failure, Acute, Extracellular Vesicles, Click Chemistry, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Acetaminophen (APAP) overdose can cause severe liver injury and life‐threatening conditions that may lead to multiple organ failure without proper treatment. N‐acetylcysteine (NAC) is the accepted and prescribed treatment for detoxification in cases of APAP overdose. Nonetheless, in acute liver failure (ALF), particularly when the ingestion is substantial, NAC may not fully restore liver function. NAC administration in ALF has limitations and potential adverse effects, including nausea, vomiting, diarrhoea, flatus, gastroesophageal reflux, and anaphylactoid reactions. Mesenchymal stromal cell (MSC)‐based therapies using paracrine activity show promise for treating ALF, with preclinical studies demonstrating improvement. Recently, MSC‐derived extracellular vesicles (EVs) have emerged as a new therapeutic option for liver injury. MSC‐derived EVs can contain various therapeutic cargos depending on the cell of origin, participate in physiological processes, and respond to abnormalities. However, most therapeutic EVs lack a distinct orientation upon entering the body, resulting in a lack of targeting specificity. Therefore, enhancing the precision of natural EV delivery systems is urgently needed. Thus, we developed an advanced targeting technique to deliver modified EVs within the body. Our strategy aims to employ bioorthogonal click chemistry to attach a targeting molecule to the surface of small extracellular vesicles (sEVs), creating exogenous chimeric antigen receptor‐modified sEVs (CAR‐sEVs) for the treatment. First, we engineered azido‐modified sEVs (N 3 ‐sEVs) through metabolic glycoengineering by treating MSCs with the azide‐containing monosaccharide N‐azidoacetyl‐mannosamine (Ac4ManNAz). Next, we conjugated N 3 ‐sEVs with a dibenzocyclooctyne (DBCO)‐tagged single‐chain variable fragment (DBCO‐scFv) that targets the asialoglycoprotein receptor (ASGR1), thus producing CAR‐sEVs for precise liver targeting. The efficacy of CAR‐sEV therapy in ALF models by targeting ASGR1 was validated. MSC‐derived CAR‐sEVs reduced serum liver enzymes, mitigated liver damage, and promoted hepatocyte proliferation in APAP‐induced injury. Overall, CAR‐sEVs exhibited enhanced hepatocyte specificity and efficacy in ameliorating liver injury, highlighting the significant advancements achievable with cell‐free targeted therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Pharmacology, National Taiwan University College of Medicine, Taipei, Taiwan.
- MediDiamond Inc., Taipei, Taiwan.
- The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
- International Ph.D. Program in Cell Therapy and Regenerative Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
- Vinmec Hi-Tech Center, Vinmec Healthcare System, Hanoi, Vietnam.
- International Ph.D. Program for Translational Science, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
ORCID-Profile: Yen-Ting Lu, Tzu-Yu Chen, Hsin-Hung Lin, Ya-Wen Chen, Yu-Xiu Lin, Andrew H-J Wang, Cheng-Chung Lee, Thai-Yen Ling
Zitieren
APA
Lu, Y. T., Chen, T. Y., Lin, H. H., Chen, Y. W., Lin, Y. X., Le, D. C., Huang, Y. H., Wang, A. H., Lee, C. C., & Ling, T. Y. (2025). Small Extracellular Vesicles Engineered Using Click Chemistry to Express Chimeric Antigen Receptors Show Enhanced Efficacy in Acute Liver Failure. Journal of Extracellular Vesicles, 14(2). https://doi.org/10.1002/jev2.70044
Vancouver
Lu YT, Chen TY, Lin HH, Chen YW, Lin YX, Le DC, et al. Small Extracellular Vesicles Engineered Using Click Chemistry to Express Chimeric Antigen Receptors Show Enhanced Efficacy in Acute Liver Failure. Journal of Extracellular Vesicles. 2025;14(2). doi:10.1002/jev2.70044
BibTeX
@article{Lu2025,
author = {Lu, Yen-Ting and Chen, Tzu-Yu and Lin, Hsin-Hung and Chen, Ya-Wen and Lin, Yu-Xiu and Le, Duy-Cuong and Huang, Yen-Hua and Wang, Andrew H-J and Lee, Cheng-Chung and Ling, Thai-Yen},
title = {Small Extracellular Vesicles Engineered Using Click Chemistry to Express Chimeric Antigen Receptors Show Enhanced Efficacy in Acute Liver Failure},
journal = {Journal of Extracellular Vesicles},
year = {2025},
volume = {14},
number = {2},
doi = {10.1002/jev2.70044}
}
EUVIMED